 John Marentette
Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urothelium | 5 | 2019 | 33 | 1.220 |
Why?
| | Dinoprostone | 2 | 2021 | 178 | 1.060 |
Why?
| | Liver Diseases, Alcoholic | 4 | 2024 | 97 | 0.920 |
Why?
| | Down Syndrome | 5 | 2023 | 522 | 0.830 |
Why?
| | Ethanol | 5 | 2024 | 625 | 0.740 |
Why?
| | Cyclooxygenase 2 | 2 | 2021 | 165 | 0.730 |
Why?
| | Urinary Bladder | 3 | 2019 | 192 | 0.600 |
Why?
| | Cystitis, Interstitial | 2 | 2016 | 20 | 0.570 |
Why?
| | Tryptases | 2 | 2015 | 12 | 0.510 |
Why?
| | Fibroblasts | 1 | 2021 | 1017 | 0.440 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2023 | 269 | 0.430 |
Why?
| | Macrophages | 2 | 2019 | 1496 | 0.410 |
Why?
| | Cysteine | 2 | 2024 | 207 | 0.380 |
Why?
| | Platelet Activating Factor | 3 | 2019 | 45 | 0.360 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2013 | 287 | 0.360 |
Why?
| | Alcohol Drinking | 1 | 2019 | 823 | 0.360 |
Why?
| | Liver | 2 | 2024 | 1884 | 0.350 |
Why?
| | Lysine | 2 | 2024 | 271 | 0.320 |
Why?
| | Cell Differentiation | 3 | 2023 | 2033 | 0.310 |
Why?
| | Epithelial Cells | 3 | 2025 | 1102 | 0.300 |
Why?
| | Smoke | 3 | 2019 | 147 | 0.270 |
Why?
| | Pyridines | 2 | 2025 | 601 | 0.240 |
Why?
| | Phenylpropionates | 1 | 2025 | 27 | 0.230 |
Why?
| | Oxylipins | 1 | 2025 | 47 | 0.220 |
Why?
| | Pyrrolidines | 1 | 2025 | 123 | 0.220 |
Why?
| | Group VI Phospholipases A2 | 2 | 2016 | 6 | 0.210 |
Why?
| | Sulfhydryl Compounds | 2 | 2023 | 187 | 0.200 |
Why?
| | Bronchi | 1 | 2025 | 262 | 0.200 |
Why?
| | Benzodioxoles | 1 | 2025 | 158 | 0.200 |
Why?
| | Quinolones | 1 | 2025 | 201 | 0.190 |
Why?
| | Aminophenols | 1 | 2025 | 201 | 0.190 |
Why?
| | Cell Line | 6 | 2025 | 2821 | 0.190 |
Why?
| | Platelet Membrane Glycoproteins | 3 | 2019 | 30 | 0.190 |
Why?
| | Proteome | 3 | 2024 | 512 | 0.180 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 370 | 0.170 |
Why?
| | Pyrazoles | 1 | 2025 | 510 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 500 | 0.170 |
Why?
| | Cyclooxygenase 1 | 1 | 2021 | 26 | 0.170 |
Why?
| | Neural Stem Cells | 1 | 2023 | 167 | 0.160 |
Why?
| | Maneb | 1 | 2020 | 9 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2019 | 231 | 0.160 |
Why?
| | Nicotinamide Mononucleotide | 1 | 2019 | 9 | 0.150 |
Why?
| | Thiolester Hydrolases | 1 | 2019 | 13 | 0.150 |
Why?
| | Oxidative Stress | 3 | 2024 | 1331 | 0.150 |
Why?
| | SNARE Proteins | 1 | 2019 | 40 | 0.150 |
Why?
| | Endothelial Cells | 3 | 2019 | 862 | 0.150 |
Why?
| | Cell Adhesion | 3 | 2019 | 451 | 0.150 |
Why?
| | Acylation | 1 | 2019 | 30 | 0.150 |
Why?
| | Mitochondria | 3 | 2023 | 981 | 0.140 |
Why?
| | Tobacco Products | 1 | 2019 | 84 | 0.130 |
Why?
| | Glutathione | 1 | 2019 | 364 | 0.130 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2014 | 24 | 0.130 |
Why?
| | Autophagy | 1 | 2019 | 284 | 0.130 |
Why?
| | Proteomics | 2 | 2023 | 1182 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2022 | 4102 | 0.120 |
Why?
| | Chagas Cardiomyopathy | 1 | 2016 | 27 | 0.120 |
Why?
| | Skin | 1 | 2021 | 751 | 0.120 |
Why?
| | Glycosaminoglycans | 1 | 2016 | 74 | 0.120 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2019 | 260 | 0.110 |
Why?
| | Hydroxyprostaglandin Dehydrogenases | 1 | 2015 | 3 | 0.110 |
Why?
| | Oxidation-Reduction | 3 | 2024 | 1073 | 0.110 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2016 | 268 | 0.110 |
Why?
| | Mice | 7 | 2024 | 18218 | 0.110 |
Why?
| | Computational Biology | 1 | 2019 | 679 | 0.100 |
Why?
| | Parkinson Disease | 1 | 2020 | 599 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4525 | 0.100 |
Why?
| | RNA | 1 | 2019 | 926 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 135 | 0.100 |
Why?
| | Immunoblotting | 1 | 2013 | 292 | 0.100 |
Why?
| | Flavonoids | 1 | 2013 | 86 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 171 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1762 | 0.090 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 264 | 0.090 |
Why?
| | Animals | 9 | 2024 | 37800 | 0.090 |
Why?
| | Imidazoles | 1 | 2013 | 246 | 0.090 |
Why?
| | Humans | 15 | 2025 | 144298 | 0.090 |
Why?
| | Smoking | 2 | 2017 | 1466 | 0.080 |
Why?
| | Carbon | 2 | 2021 | 200 | 0.080 |
Why?
| | Tobacco Smoke Pollution | 1 | 2011 | 227 | 0.070 |
Why?
| | Phosphorylation | 1 | 2013 | 1702 | 0.070 |
Why?
| | Mice, Knockout | 4 | 2019 | 3106 | 0.070 |
Why?
| | Drug Combinations | 1 | 2025 | 392 | 0.050 |
Why?
| | Acetylation | 1 | 2024 | 244 | 0.050 |
Why?
| | Lung | 2 | 2014 | 4084 | 0.050 |
Why?
| | Click Chemistry | 1 | 2023 | 53 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2019 | 5954 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2024 | 466 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2014 | 2363 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2589 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2023 | 565 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 32 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| | Lactoylglutathione Lyase | 1 | 2019 | 12 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 601 | 0.040 |
Why?
| | Pyruvaldehyde | 1 | 2019 | 20 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2019 | 85 | 0.040 |
Why?
| | Protective Agents | 1 | 2019 | 42 | 0.040 |
Why?
| | Alkynes | 1 | 2019 | 66 | 0.040 |
Why?
| | Glycosylation | 1 | 2019 | 160 | 0.040 |
Why?
| | Ginkgolides | 1 | 2019 | 4 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2019 | 151 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 128 | 0.040 |
Why?
| | Female | 4 | 2021 | 78137 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 48 | 0.040 |
Why?
| | Male | 3 | 2021 | 72263 | 0.040 |
Why?
| | Lactones | 1 | 2019 | 58 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 194 | 0.030 |
Why?
| | Sirtuin 3 | 1 | 2019 | 58 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2019 | 245 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 436 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 186 | 0.030 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2019 | 175 | 0.030 |
Why?
| | Glycolysis | 1 | 2019 | 340 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 741 | 0.030 |
Why?
| | Parasite Load | 1 | 2016 | 10 | 0.030 |
Why?
| | Chondroitin ABC Lyase | 1 | 2016 | 1 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1360 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 383 | 0.030 |
Why?
| | Nitrites | 1 | 2016 | 89 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 847 | 0.030 |
Why?
| | Signal Transduction | 2 | 2019 | 5182 | 0.030 |
Why?
| | Permeability | 1 | 2016 | 168 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 461 | 0.030 |
Why?
| | Tight Junctions | 1 | 2016 | 81 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1161 | 0.030 |
Why?
| | Ovariectomy | 1 | 2016 | 163 | 0.030 |
Why?
| | Gene Deletion | 1 | 2016 | 388 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2014 | 131 | 0.030 |
Why?
| | Wound Healing | 1 | 2017 | 345 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 722 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1809 | 0.020 |
Why?
| | Phospholipid Ethers | 1 | 2011 | 4 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 819 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3520 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2512 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6387 | 0.020 |
Why?
| | Neutrophils | 1 | 2011 | 1115 | 0.010 |
Why?
| | Infant | 1 | 2019 | 10011 | 0.010 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 919 | 0.010 |
Why?
| | Inflammation | 1 | 2011 | 2862 | 0.010 |
Why?
|
|
Marentette's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|